|
| Press Releases |
|
 |
|
| Wednesday, August 3, 2022 |
|
|
Zhaoke Ophthalmology Completed Patient Enrollments for the Phase III Clinical Trials of the Myopia Progression Treatment Drug NVK002 |
| Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or "the Company", SEHK: 6622), a leading ophthalmic pharmaceutical company dedicated to the research and development more info >> |
|
| Monday, November 15, 2021 |
|
|
兆科眼科获选于2021年美国眼科学会年会Eyecelerator@AAO上发表演讲 |
| 致力于眼科疗法的研究、开发及商业化，以满足巨大医疗需求缺口的领先眼科制药企业兆科眼科有限公司（「兆科眼科」；香港联交所股份代号：6622）获选于2021年11月11日在美国新奥尔良举行的2021年美国眼科学会年会Eyecelerator@AAO上发表演讲。 more info >> |
|
|
兆科眼科獲選於2021年美國眼科學會年會Eyecelerator@AAO上發表演講 |
| 致力於眼科療法的研究、開發及商業化，以滿足巨大醫療需求缺口的領先眼科製藥企業兆科眼科有限公司（「兆科眼科」；香港聯交所股份代號：6622）獲選於2021年11月11日在美國新奧爾良舉行的2021年美國眼科學會年會Eyecelerator@AAO上發表演講。 more info >> |
|
| Monday, May 24, 2021 |
|
|
兆科眼科(6622.HK)两项产品通过国家药监局药品注册现场核查及GMP符合性检查 |
| 致力于眼科疗法的研究、开发及商业化的眼科制药公司——兆科眼科有限公司(「兆科眼科」或「公司」；股份代号：6622)，宣布两项药品——贝美素噻吗洛尔滴眼液(在中国用于治疗青光眼的潜在首仿药 more info >> |
|
|
兆科眼科(6622.HK)兩項產品通過國家藥監局藥品註冊現場核查及GMP符合性檢查 |
| 致力於眼科療法的研究、開發及商業化的眼科製藥公司——兆科眼科有限公司(「兆科眼科」或「公司」；股份代號：6622)，宣佈兩項藥品——貝美素噻嗎洛爾滴眼液(在中國用於治療青光眼的潛在首仿藥 more info >> |
|
|
Two Products of Zhaoke Ophthalmology (6622.HK) Passes On-Site Inspection for Drug Registration by National Medical Products Administration and GMP Compliance Inspection by Guangdong Medical Products Administration |
| Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or the "Company"; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Krypto Miners Club Releases Revolutionary NFT Collection Backed by BTC Mining on Polygon Blockchain
Mar 26, 2023 02:02: JST
|
|
|
Krypto Miners Club Releases Revolutionary NFT Collection Backed by BTC Mining on Polygon Blockchain
Mar 26, 2023 01:02 HKT/SGT
|
|
|
Prime Miami Bayfront Site Announced by Urban Core
Mar 26, 2023 00:00 HKT/SGT
|
|
|
Prime Miami Bayfront Site Announced by Urban Core
Mar 26, 2023 00:00 HKT/SGT
|
|
|
天能动力公布2022年全年业绩
Mar 25, 2023 09:57 HKT/SGT
|
|
|
天能動力公佈2022年全年業績
Mar 25, 2023 09:56 HKT/SGT
|
|
|
Tianneng Power Announces 2022 Annual Results
Mar 25, 2023 09:55 HKT/SGT
|
|
|
天韵国际公布2022年全年业绩
Mar 24, 2023 23:24 HKT/SGT
|
|
|
天韵國際公佈2022年全年業績
Mar 24, 2023 23:23 HKT/SGT
|
|
|
Tianyun International Announced 2022 Annual Results
Mar 24, 2023 23:22 HKT/SGT
|
|
|
安乐工程2022全年收益及获授合约逆市增加21.0%及41.8%
Mar 24, 2023 22:11 HKT/SGT
|
|
|
安樂工程2022全年收益及獲授合約逆市增加21.0%及41.8%
Mar 24, 2023 22:10 HKT/SGT
|
|
|
Analogue Grows FY2022 Revenue and Contracts Awarded by 21.0% and 41.8% Respectively Defying Challenging Market Conditions
Mar 24, 2023 22:09 HKT/SGT
|
|
|
四环医药（0460.HK）发布2022年全年业绩
Mar 24, 2023 19:18 HKT/SGT
|
|
|
四環醫藥（0460.HK）發佈2022年全年業績
Mar 24, 2023 19:17 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
